ENGERIX-B PEDIATRIC DOSE 10 MCG/0.5ML 1 INJECTOR – 2026 Price Turkey

by

Clinical Data Review: Comprehensive profile for ENGERIX-B PEDIATRIC DOSE 10 MCG/0.5ML 1 INJECTOR, including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: ENGERIX-B PEDIATRIC DOSE 10 MCG/0.5ML 1 INJECTOR

Manufacturer: GLAXOSMITHKLINE PHARMACEUTICALS INDUSTRY AND TRADE INC.

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

HEPATIT B 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

ENGERIX-B PEDIATRIC DOSE 10 MCG/0.5ML 1 INJECTOR is formulated with HEPATIT B, a clinically established agent in medical practice.

  • Mechanism of Action: HEPATIT B acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to HEPATIT B therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name ENGERIX-B PEDIATRIC DOSE 10 MCG/0.5ML 1 INJECTOR
Barcode (GTIN) 8699522967117
Generic Name HEPATIT B
License Holder GLAXOSMITHKLINE PHARMACEUTICALS INDUSTRY AND TRADE INC.
Pharmacy Retail Price 650.6 TL
⚠️ Clinical Safety Warning

Do not administer ENGERIX-B PEDIATRIC DOSE 10 MCG/0.5ML 1 INJECTOR if the patient has a known hypersensitivity or allergy to HEPATIT B. Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.

Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via GLAXOSMITHKLINE PHARMACEUTICALS INDUSTRY AND TRADE INC..

Leave a Comment